1 Novel Tumor Markers
R. Hoffmann, E.P. Romijn, H.M. Visser, T. Hulsen
WO2011027308, 2011-03-10
2 Novel Tumor Markers
R. Hoffmann, E.P. Romijn, H.M. Visser, T. Hulsen
WO2011027310, 2011-03-10
3 Novel Tumor Markers
R. Hoffmann, E.P. Romijn, H.M. Visser, T. Hulsen
WO2011027311, 2011-03-10
4 Novel Tumor Markers Selected From A Group Of cAMP-regulatory Pathway Members
R. Hoffmann, E.P. Romijn, H.M. Visser, T. Hulsen
WO2011027312, 2011-03-10
5 Novel Tumor Markers
R. Hoffmann, H.M. Visser, T. Hulsen, L. Waanders, E.P. Romijn
WO2011073896, 2011-06-23
6 Novel Tumor Markers
R. Hoffmann, H.M. Visser, E.P. Romijn, L. Waanders, D. Merkle, T. Hulsen
WO2011073901, 2011-06-23
7 Novel Tumor Markers
R. Hoffmann, H.M. Visser, E.P. Romijn, L. Waanders, D. Merkle, T. Hulsen
WO2011073903, 2011-06-23
8 Data Model Mapping
T. Hulsen, W.P.M. van der Linden, D. Pletea, J.H. Obbink, M. Quist
WO2017167628, 2017-10-05
9 Disease-Oriented Genomic Anonymization
D. Pletea, T. Hulsen, W.P.M. van der Linden, P. van Liesdonk
US2019333607, 2019-10-31
10 Method Of Anonymizing Genomic Data
T. Hulsen, D. Pletea
WO2022090067, 2022-05-05
11 Variable Allele Frequency Threshold
T. Hulsen, P. van de Zaag, G. Raaijmakers
WO2022243149, 2022-11-23